On Monday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) opened lower -3.01% from the last session, before settling in for the closing price of $1.66. Price fluctuations for SLS have ranged from $0.77 to $2.12 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 33.00% at the time writing. With a float of $97.67 million, this company’s outstanding shares have now reached $99.78 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SELLAS Life Sciences Group Inc is 2.11%, while institutional ownership is 14.33%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 33.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.68% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
Check out the current performance indicators for SELLAS Life Sciences Group Inc (SLS). In the past quarter, the stock posted a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.39, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.38 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Looking closely at SELLAS Life Sciences Group Inc (NASDAQ: SLS), its last 5-days average volume was 2.23 million, which is a drop from its year-to-date volume of 2.44 million. As of the previous 9 days, the stock’s Stochastic %D was 58.97%. Additionally, its Average True Range was 0.13.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 59.83%, which indicates a significant increase from 27.45% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 68.32% in the past 14 days, which was lower than the 101.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5142, while its 200-day Moving Average is $1.2608. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.6867. Second resistance stands at $1.7633. The third major resistance level sits at $1.8167. If the price goes on to break the first support level at $1.5567, it is likely to go to the next support level at $1.5033. Now, if the price goes above the second support level, the third support stands at $1.4267.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are currently 99,777K shares outstanding in the company with a market cap of 160.64 million. Presently, the company’s annual sales total 0 K according to its annual income of -30,880 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -5,810 K.
